Mycobacterium kansasii: Antibiotic susceptibility and PCR-restriction analysis of clinical isolates

Journal of Medical Microbiology

Volumn 54, Issue 10, 2005, Pages 975-979

  Da Silva Telles, Maria Alice ^a   Chimara, Erica ^a   Ferrazoli, Lucilaine ^a   Riley, Lee W ^b  

^a INSTITUTO ADOLFO LUTZ   (Brazil)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CIPROFLOXACIN; CLARITHROMYCIN; CLOFAZIMINE; CYCLOSERINE; DOXYCYCLINE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; RESTRICTION ENDONUCLEASE; RIFABUTIN; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; ENZYME ANALYSIS; GENOTYPE; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIOSIS; MYCOBACTERIUM KANSASII; NONHUMAN; POLYMERASE CHAIN REACTION; POLYMERASE CHAIN REACTION RESTRICTION ENZYME PATTERN ANALYSIS; PRIORITY JOURNAL;

EID: 25844466533     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.45965-0     Document Type: Article

References (33)

1. Ahn, C. H., McLarty, J. W., Ahn, S. S., Ahn, I. & Hurst, G. A. (1982). Diagnostic criteria for pulmonary disease caused by Mycobacterium kansasii and Mycobacterium intracellulare. Am Rev Respir Dis 125, 388-391.
2. Alcaide, F., Richter, I., Bernasconi, C. & 7 other authors (1997). Heterogeneity and clonality among isolates of Mycobacterium kansasii: implications for epidemiological and pathogenicity studies. J Clin Microbiol 35, 1959-1964.
3. Alcaide, F., Benitez, M. A. & Martin, R. (1999). Epidemiology of Mycobacterium kansasii. Ann Intern Med 131, 310-311.
4. American Thoracic Society (1990). Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am Rev Respir Dis 142, 940-953.
5. American Thoracic Society (1997). Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Resp Crit Care Med 156, S1-S25.
6. Bamberger, D. M., Driks, M. R., Gupta, M. R., O'Connor, M. C., Jost, P. M., Neihart, R. E., McKinsey, D. S., Moore, L. A. & the Kansas City AIDS Research Consortium (1994). Mycobacterium kansasii among patients infected with the human immunodeficiency virus in Kansas City. Clin Infect Dis 18, 395-400.
7. Bittner, M. J., Horowitz, E. A., Safranek, T. J. & Preheim, L. C. (1996). Emergence of Mycobacterium kansasii as the leading mycobacterial pathogen isolated over a 20-year period at a midwestern Veterans Affairs hospital. Clin Infect Dis 22, 1109-1110.
8. Bloch, K. C., Zwerling, L., Pletcher, M. J., Hahn, J. A., Gerberding, J. L., Ostroff, S. M., Vugia, D. J. & Reingold, A. L. (1998). Incidence and clinical implications of isolation of Mycobacterium kansasii: results of a 5-year, population-based study. Ann Intern Med 129, 698-704.
9. Bolivar, R., Satterwhite, K. T. & Floyd, M. (1980). Cutaneous lesions due to Mycobacterium kansasii. Arch Dermatol 116, 207-208.
10. Chobot, S., Malis, J., Sebakova, H., Pelikan, M., Zatloukal, O., Palicka, P. & Kocurova, D. (1997). Endemic incidence of infections caused by Mycobacterium kansasii in the Karvina district in 1968-1995 (analysis of epidemiological data - review). Cent Eur J Public Health 5, 164-173.
11. Evans, S. A., Colville, A., Evans, A. J., Crisp, A. J. & Johnston, I. D. A. (1996). Pulmonary Mycobacterium kansasii infection: comparison of the clinical features, treatment and outcome with pulmonary tuberculosis. Thorax 51, 1248-1252.
12. Ferrazoli, L., Silva, E. A. M., Martins, M. C., Ichikawa, T. & Palaci, M. (1992). Mycobacteria other than M. tuberculosis. Important aspects concerning frequency and diagnosis of infection. Hansen Int 17, 15-20 (in Portuguese).
13. Inderlied, C. B. & Pfyffer, G. E. (2003). Susceptibility test methods: Mycobacteria. In Manual of Clinical Microbiology, 8th edn, pp. 1149-1177. Washington, DC: American Society for Microbiology.
14. Nachamkin, I., MacGregor, R. R., Staneck, J. L., Tsang, A. Y., Denner, J. C., Willner, M. & Barbagallo, S. (1992). Niacin-positive Mycobacterium kansasii isolated from immunocompromised patients. J Clin Microbiol 30, 1344-1346.
15. Picardeau, M., Prodhom, G., Raskine, L., Lepennec, M. P. & Vincent, V. (1997). Genotypic characterization of five subspecies of Mycobacterium kansasii. J Clin Microbiol 35, 25-32.
16. Rooney, G., Nelson, M. R. & Gazzard, B. (1996). Mycobacterium kansasii: its presentation, treatment and outcome in HIV infected patients. J Clin Pathol 49, 821-823.
17. Ross, B. C., Jackson, K., Yang, M., Sievers, A. & Dwyer, B. (1992). Identification of a genetically distinct subspecies of Mycobacterium kansasii. J Clin Microbiol 30, 2930-2933.
18. Sato, D. N., Silva, E. A. M., Ferrazoli, L. & Palaci, M. (1993). 'In vitro' activity of different drugs against Mycobacterium kansasii. Rev Inst Adolfo Lutz 53, 55-58 (in Portuguese).
19. Schraufnagel, D. E., Leech, J. A. & Pollak, B. (1986). Mycobacterium kansasii: colonization and disease. Br J Dis Chest 80, 131-137.
20. Shafer, R. W. & Sierra, M. F. (1992). Mycobacterium xenopi, Mycobacterium fortuitum, Mycobacterium kansasii, and other nontuberculous mycobacteria in an area of endemicity for AIDS. Clin Infect Dis 15, 161-162.
21. Sherer, R., Sable, R., Sonnenberg, M., Cooper, S., Spencer, P., Schwimmer, S., Kocka, F., Muthuswamy, P. & Kallick, C. (1986). Disseminated infection with Mycobacterium kansasii in the acquired immunodeficiency syndrome. Ann Intern Med 105, 710-711.
22. Silva, E. A. M., Miranda, J. B. N., Ferrazoli, L., Alge, M. E., Silva, R. R. F., Fuzihara, T. O. & Palaci, M. (1987). Pulmonary infections due to M. kansasii in Sao Paulo, Brazil. Rev Inst Adolfo Lutz 47, 11-17 (in Portuguese).
23. Taillard, C., Greub, G., Weber, R. & 11 other authors (2003). Clinical implications of Mycobacterium kansasii species heterogeneity: Swiss national survey. J Clin Microbiol 41, 1240-1244.
24. Telenti, A., Marchesi, F., Balz, M., Bally, F., Bottger, E. C. & Bodmer, T. (1993). Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J Clin Microbiol 31, 175-178.
25. Telles, M. A. S. & Yates, M. D. (1994). Single and double drug susceptibility testing of Mycobacterium avium complex and mycobacteria other than the tubercle (MOTT) bacilli by a micro-dilution broth minimum inhibitory concentration (MIC) method. Tuber Lung Dis 75, 286-290.
26. Valainis, G. T., Cardona, L. M. & Greer, D. L. (1991). The spectrum of Mycobacterium kansasii disease associated with HIV-I infected patients. J Acquir Immune Defic Syndr 4, 516-520.
27. Wallace, R. J., Jr, Nash, D. R., Steele, L. C. & Steingrube, V. A. (1986). Susceptibility testing of slowly growing mycobacteria by a microdilution MIC method with 7H9 broth. J Clin Microbiol 24, 976-981.
28. Witzig, R. S. & Franzblau, S. G. (1993). Susceptibility of Mycobacterium kansasii to ofloxacin, sparfloxacin, clarithromycin, azithromycin, and fusidic acid. Antimicrob Agents Chemother 37, 1997-1999.
29. Witzig, R. S., Fazal, B. A., Mera, R. M., Mushatt, D. M., Dejace, P. M., Greer, D. L. & Hyslop, N. E., Jr (1995). Clinical manifestations and implications of coinfection with Mycobacterium kansasii and human immunodeficiency virus type 1. Clin Infect Dis 21, 77-85.
30. Wolinsky, E. (1979). Nontuberculous mycobacteria and associated diseases. Am Rev Respir Dis 119, 107-159.
31. Wolinsky, E. (1981). When is an infection disease? Rev Infect Dis 3, 1025-1027.
32. Woods, G. L. & Washington, J. A. (1987). Mycobacteria other than Mycobacterium tuberculosis: review of microbiologic and clinical aspects. Rev Infect Dis 9, 275-294.
33. Zhang, Y., Mann, L. B., Wilson, R. W., Brown-Elliott, B. A., Vincent, V., Iinuma, Y. & Wallace, R. J., Jr (2004). Molecular analysis of Mycobacterium kansasii isolates from the United States. J Clin Microbiol 42, 119-125.